LeMaitre Vascular, Inc. (LMAT)
Automate Your Wheel Strategy on LMAT
With Tiblio's Option Bot, you can configure your own wheel strategy including LMAT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol LMAT
- Rev/Share 10.0246
- Book/Share 15.3997
- PB 5.2644
- Debt/Equity 0.5333
- CurrentRatio 16.4927
- ROIC 0.0765
- MktCap 1831728008.0
- FreeCF/Share 1.8218
- PFCF 44.5492
- PE 40.5153
- Debt/Assets 0.3334
- DivYield 0.0089
- ROE 0.1353
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | LMAT | Barrington Research | Outperform | Market Perform | -- | -- | Feb. 28, 2025 |
| Downgrade | LMAT | Oppenheimer | Outperform | Perform | -- | -- | Feb. 28, 2025 |
| Initiation | LMAT | Wells Fargo | -- | Equal Weight | -- | $95 | Feb. 13, 2025 |
| Initiation | LMAT | Cantor Fitzgerald | -- | Neutral | -- | $96 | Oct. 15, 2024 |
News
LeMaitre (LMAT) Soars 7.7%: Is Further Upside Left in the Stock?
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
LeMaitre (LMAT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Read More
4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Neutral
Healthcare stocks like GLID, COR, FMS and LMAT are a safe bet during times of market volatility.
Read More
Small-Cap Dividend Stocks: Hidden Gems Or High-Risk Plays? - Top U.S. And Canadian Ones
Published: April 04, 2025 by: Seeking Alpha
Sentiment: Neutral
Over the past decade, the iShares S&P/TSX SmallCap Index ETF has underperformed broader markets due to its heavy exposure to resource-heavy sectors like energy and materials. Acme's dividend track record spans over 15 years, with a modest but steady payout. Debt levels remain low, and management is highly focused on operational efficiency. With regulated pricing, recurring revenue, and defensive characteristics, York Water is a favorite for income-seekers looking for small-cap stability.
Read More
3 Reasons Growth Investors Will Love LeMaitre (LMAT)
Published: March 25, 2025 by: Zacks Investment Research
Sentiment: Positive
LeMaitre (LMAT) could produce exceptional returns because of its solid growth attributes.
Read More
Precision Optics Appoints Joseph P. Pellegrino, Jr. to Board of Directors
Published: March 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
GARDNER, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, is pleased to announce the appointment of Joseph P.
Read More
When Do You Sell A Winner? - January Dividend Income Report
Published: March 04, 2025 by: Seeking Alpha
Sentiment: Neutral
BlackRock is an interesting case study as I sold it for a nice profit even though the company's investment thesis is still intact. However, some metrics aren't as strong as before. I have a Telus position in one of my other portfolios. I've actively monitored its cash flow metrics. Brookfield Renewable reported another solid quarter with FFO per unit up 21%. The company's hydroelectric, wind, solar, and distributed energy businesses all contributed positively despite weaker North American hydrology affecting hydroelectric generation.
Read More
Best Momentum Stocks to Buy for March 4th
Published: March 04, 2025 by: Zacks Investment Research
Sentiment: Positive
OPCH and LMAT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 4, 2025.
Read More
LeMaitre Vascular, Inc. (LMAT) Q4 2024 Earnings Call Transcript
Published: February 27, 2025 by: Seeking Alpha
Sentiment: Neutral
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chief Executive Officer Dave Roberts - President Conference Call Participants Nathan Treybeck - Wells Fargo Danny Stauder - Citizens JMP Matthew Park - Cantor Fitzgerald Frank Takkinen - Lake Street Capital Markets Michael Petusky - Barrington Research Jim Sidoti - Sidoti & Company Operator Welcome to the LeMaitre Vascular Q4 2024 Financial Results Conference Call.
Read More
LeMaitre Vascular (LMAT) Meets Q4 Earnings Estimates
Published: February 27, 2025 by: Zacks Investment Research
Sentiment: Positive
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.49 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.38 per share a year ago.
Read More
About LeMaitre Vascular, Inc. (LMAT)
- IPO Date 2006-10-19
- Website https://www.lemaitre.com
- Industry Medical - Instruments & Supplies
- CEO Mr. George W. LeMaitre
- Employees 651